Lawsuit Update Center
Internal bra mesh lawsuits are being filed by women who say surgical mesh used in breast augmentation, breast lift, breast reduction, revision, or post-mastectomy reconstruction caused serious injuries instead of support. Our lawyers are handling these claims.
These cases involve products such as GalaFLEX, GalaFLEX Lite, GalaFLEX 3D, GalaFLEX 3DR, Phasix Mesh, Phasix ST Mesh, and other synthetic or biologic mesh products used to reinforce breast tissue or support implants. The core claims are that the mesh caused infection, chronic pain, nerve damage, seroma, inflammation, capsular contracture, mesh exposure, implant malposition, reconstruction failure, disfigurement, revision surgery, or removal surgery.
An internal bra is a surgical technique. The mesh is placed inside the breast to provide support beneath the tissue or implant. When it works, the goal is lift, support, and stability. When it fails, the patient can be left with pain, infection, hardening, scarring, deformity, implant loss, or a surgery that has to be redone.
If you had breast mesh placed during augmentation, lift, reduction, revision, or reconstruction and later suffered infection, chronic pain, seroma, mesh exposure, implant shifting, implant removal, mesh removal, reconstruction failure, or revision surgery, contact our office today at 888-322-3010, or get a free online consultation.
Internal Bra Mesh Lawsuit Updates
The internal bra mesh litigation is still in the early stages. Lawyers are investigating and filing individual product liability claims for women who say breast mesh caused serious complications after augmentation, lift, reduction, revision, or reconstruction surgery.
The strongest update for plaintiffs remains the FDA’s commentary. The FDA has indicated that there are no surgical mesh products cleared or approved for use in breast surgery, including augmentation or reconstruction. That does not automatically prove any individual case. But it gives plaintiffs a direct issue to build around.
| Development | What Happened | Why It Helps Explain the Litigation |
|---|---|---|
| Rhode Island GalaFLEX lawsuits | Recent legal reporting describes GalaFLEX breast mesh lawsuits filed in Rhode Island state court against Becton Dickinson and related entities, including Davol, C.R. Bard, Tepha, and Galatea. The complaints reportedly allege nerve pain, swelling, breast ptosis, seroma, inflammation, improper dissolution, revision surgery, and mesh removal. | These filings show the litigation is moving from investigation into filed cases. They also show the main plaintiff theory: the product was allegedly sold or promoted for breast procedures without adequate breast-specific warnings. |
| FDA BD mesh labeling update | In November 2023, the FDA issued a letter to health care providers about BD labeling updates for Phasix Mesh, Phasix ST Mesh, GalaFLEX Lite Scaffold, GalaFLEX Scaffold, GalaFLEX 3D Scaffold, and GalaFLEX 3DR Scaffold. The FDA said these products are cleared for soft-tissue reinforcement where weakness exists, but the FDA has not determined their safety and effectiveness in breast surgery. | This is the central warning issue. Plaintiffs will argue that companies knew mesh was being used as an internal bra and should have given clearer breast surgery warnings sooner. |
| FDA ADM safety communication | In 2021, the FDA warned about differing complication rates associated with acellular dermal matrix (ADM) in implant-based breast reconstruction. The FDA said FlexHD and AlloMax showed higher rates of explantation, reoperation, and infection in the data reviewed. | ADM cases are not identical to synthetic mesh cases. But the warning supports the broader plaintiff theme: the use of mesh in breast reconstruction raises product-specific safety and disclosure questions. |
| 2024 synthetic mesh review | A 2024 review in Aesthetic Surgery Journal Open Forum analyzed outcomes of synthetic mesh use in alloplastic breast reconstruction. The review reported short-term rates of seroma, infection, reoperation, and explant, and stated that no mesh had FDA approval for that breast reconstruction indication. | The medical literature is not one-sided. Some studies report acceptable short-term outcomes in selected patients. Plaintiffs will focus on the gap between reported outcomes, patient injuries, long-term uncertainty, and warnings. |
| Recall status | There is no broad public FDA recall of internal bra mesh products for breast surgery. The FDA also said it is not recommending reoperation or removal of implanted surgical mesh in patients without symptoms. | A recall is not required to bring a product liability case. But if you have symptoms, have undergone revision surgery, or have a mesh removal recommendation, the records need to be reviewed now. |
| No public breast mesh settlement yet | Current public settlement reporting indicates that internal bra mesh claims are in the early stages, with no public breast mesh settlements or jury verdicts yet. | There is no honest average payout yet. Case value will come from injury severity, product proof, medical causation, deadline posture, and discovery showing manufacturer conduct. |
What These Lawsuits Are About
An internal bra mesh lawsuit usually starts with a patient who had a breast procedure and then developed a complication that was not supposed to happen, or happened in a way that required serious medical care. The question is what changed after the mesh was implanted. Did you develop an infection? Did the implant shift? Did the breast harden? Did you develop pain where the mesh was placed? Did the mesh become visible or exposed? Did the reconstruction fail? Did your surgeon recommend revision or removal? These are the question we ask and they drive liability.
Details drive these cases; the strongest cases are specific. There are two main lanes. A product liability case focuses on the mesh manufacturer, labeling, testing, warnings, marketing, sales practices, and the company’s knowledge of its use in breast procedures. A malpractice case focuses on the surgeon, informed consent, patient selection, surgical placement, infection response, and follow-up care. Some cases require both analyses.
Most internal bra mesh claims our lawyers review are, first, product liability claims. The target is usually the company that produced or sold the mesh. But if the medical records show poor placement, ignored signs of infection, or a failure to warn you that the product was not FDA-cleared or approved for breast surgery, the surgeon’s side of the case also needs to be evaluated.
Who May Have an Internal Bra Mesh Claim?
You may have a claim if mesh was placed during a breast procedure and you later suffered serious complications that required treatment, revision surgery, implant removal, mesh removal, hospitalization, wound care, or left you with lasting pain or disfigurement.
You do not need to know the exact mesh product before calling. That information is usually in the operative report, product sticker sheet, implant log, supply record, or revision surgery records. If your records only say “mesh,” that does not end the review. It means we need the complete chart.
Product Failure Claim
Mesh migration, mesh exposure, poor integration, implant malposition, failure to dissolve as expected, chronic inflammation, or failure requiring revision or removal.
Failure to Warn Claim
The company allegedly failed to give adequate warnings about infection, pain, seroma, mesh exposure, implant failure, reconstruction failure, removal difficulty, or revision risk.
Off-Label Promotion Claim
The manufacturer allegedly promoted or supported the use of mesh in breast surgery even though FDA clearance did not establish safety and effectiveness for that use.
Serious Injury Claim
Infection, abscess, chronic pain, nerve damage, capsular contracture, tissue necrosis, implant loss, mesh removal, reconstruction failure, or permanent deformity.
A minor cosmetic disappointment is probably not enough for a strong lawsuit. The stronger claims involve objective medical evidence, additional procedures, documented mesh problems, and a clear before-and-after injury story.
Legal Theories in Internal Bra Mesh Cases
Our lawyers’ approach to a case depends on the target. If the claim is against BD, Bard, Davol, Tepha, Galatea, Integra, Allergan, AbbVie, MTF Biologics, or another manufacturer, the case may involve failure to warn, defective design, negligent marketing, negligent misrepresentation, breach of warranty, or failure to comply with federal reporting and labeling duties.
The defense will usually argue that complications are known risks of breast surgery, that the surgeon chose the product, that the mesh was cleared for soft tissue reinforcement, and that the patient had other risk factors. Plaintiffs answer with records, product history, FDA language, company documents, and medical evidence that tie the complication to the mesh.
| Theory | What Plaintiff Must Show | Evidence That Helps |
|---|---|---|
| Failure to warn | The manufacturer allegedly knew or should have known about breast surgery risks and failed to adequately warn surgeons or patients. | Labels, instructions for use, FDA communications, physician letters, sales materials, product advisories, and surgeon testimony. |
| Defective design | The product allegedly created an unreasonable risk of infection, chronic inflammation, mesh exposure, migration, pain, or failure in breast tissue. | Explanted mesh, pathology, revision findings, medical literature, adverse event reports, design documents, and expert review. |
| Off-label promotion | The company allegedly promoted or encouraged breast surgery use even though FDA clearance did not establish safety and effectiveness for that use. | Sales representative communications, training materials, brochures, surgeon webinars, reimbursement materials, and company marketing history. |
| Inadequate testing | The manufacturer allegedly sold mesh for breast procedures without enough breast-specific clinical testing or long-term safety data. | FDA submissions, clinical studies, internal risk reviews, surgeon complaints, post-market surveillance, and expert regulatory analysis. |
| Medical malpractice | The surgeon or medical provider allegedly failed to obtain informed consent, selected the wrong patient, placed the mesh improperly, or ignored complications. | Consent forms, consultation notes, operative reports, follow-up records, wound care notes, infection records, and revision findings. |
Internal Bra Mesh Products Under Review
The product name controls the manufacturer’s claim. Do not guess. The right answer is usually in the operative report, implant log, product sticker sheet, hospital supply record, or revision records.
The FDA’s 2023 letter specifically addressed BD labeling updates for Phasix and GalaFLEX products. Other mesh and ADM products may still appear in breast surgery records, but each product must be evaluated based on its own label, manufacturer history, material, warnings, and use in your procedure.
| Product or Product Family | Common Product Type | Company Commonly Associated With Product | Why It Is Being Reviewed |
|---|---|---|---|
| GalaFLEX, GalaFLEX Lite, GalaFLEX 3D, GalaFLEX 3DR | Synthetic absorbable P4HB scaffold | BD, Tepha, Galatea related product history | Named in FDA labeling updates and recent internal bra mesh lawsuits. |
| Phasix Mesh and Phasix ST Mesh | Synthetic absorbable P4HB mesh | BD, C.R. Bard, Davol related product history | Included in the FDA labeling update and used for soft tissue reinforcement applications. |
| DuraSorb | Synthetic absorbable mesh | Integra LifeSciences | May appear in breast reconstruction and internal support records. Product proof and injury proof control the claim. |
| AlloDerm and Strattice | Acellular dermal matrix | LifeCell, Allergan, AbbVie related product history | ADM products have been used in implant-based reconstruction. The FDA has discussed ADM complication rates in breast reconstruction. |
| FlexHD and AlloMax | Acellular dermal matrix | MTF Biologics for FlexHD, BD related history for AlloMax | The FDA identified higher complication rates for certain ADM products in implant-based breast reconstruction data. |
| SurgiMend and OviTex PRS | Biologic or reinforced tissue matrix, depending on the product | Integra for SurgiMend, TELA Bio for OviTex PRS | May appear in breast reconstruction records and adverse event reviews. The claim depends on the product and injury record. |
Common Injuries and Complications
Internal bra mesh complications range from treatable to life-altering. The lawsuit’s settlement value depends heavily on that range. A minor scar concern is not the same as infection, implant loss, failed reconstruction, or permanent disfigurement.
If your complication required antibiotics, wound care, drainage, revision surgery, capsulectomy, implant removal, mesh removal, or reconstruction repair, your records should be reviewed. The injuries most likely to support a strong claim are those that are medically documented and tied to the mesh location or pocket.
| Complication | What It Can Look Like | What It Means |
|---|---|---|
| Infection or abscess | Redness, fever, swelling, drainage, wound breakdown, hospitalization, antibiotics, implant removal, or mesh removal. | Infections that require surgery can drive medical bills, scarring, pain, implant loss, and reconstruction failure. |
| Chronic breast pain or nerve pain | Burning, stabbing, pulling, tenderness over the mesh, pain with movement, pain during sleep, or pain lasting months or years. | Long-term pain can have real value when treatment records and evidence of daily impact support it. |
| Seroma or hematoma | Fluid buildup, swelling, drainage procedures, aspiration, blood collection, or repeated office visits. | Fluid collection can support a mesh-related inflammation or failure theory, especially when it leads to revision surgery. |
| Capsular contracture | Hardening around the implant, tightness, distortion, pain, high-riding implant, or need for capsulectomy. | Severe contracture requiring revision surgery is more significant than mild tightness without treatment. |
| Mesh migration, exposure, or erosion | Mesh can be felt, seen, exposed through tissue, displaced, detached, or involved in wound breakdown. | Visible exposure or documented movement more directly ties the injury to the device. |
| Implant malposition or bottoming out | Implant drops, shifts, rotates, becomes uneven, or causes visible asymmetry. | These claims are stronger when the mesh was used specifically to prevent the problem that happened. |
| Reconstruction failure or implant loss | Loss of implant, failed tissue expander, abandoned reconstruction plan, or need for flap surgery. | Implant loss and failed reconstruction can create serious damage because they affect body image, future care, and emotional harm. |
| Tissue necrosis, scarring, or deformity | Tissue death, open wounds, severe scarring, breast distortion, nipple loss, or visible disfigurement. | Permanent visible injury is a major driver of damages, especially in photographs and revision records. |
Internal Bra Mesh Settlements and Verdicts
There are no public average settlement amounts for internal bra mesh lawsuits. Current public reporting says internal bra claims are still in the beginning stages, and there have been no public breast mesh settlements or jury verdicts yet.
That does not mean the claims have no value. It means no reliable settlement range has been built yet through discovery, bellwether trials, or a global settlement program. Any website giving a precise average payout is guessing unless it is talking about a different mesh litigation.
| Settlement Issue | Current Posture | What It Means for Plaintiffs |
|---|---|---|
| No public global breast mesh settlement | There is no public global settlement for internal bra mesh claims as of this update. | Claim value will be determined on a case-by-case basis through medical records, product evidence, expert review, and discovery. |
| No public breast mesh verdicts yet | No public internal bra mesh jury verdict has created a damages benchmark. | Early cases with severe injuries may become the cases that set settlement pressure later. |
| Related BD hernia mesh settlement | In 2024, BD announced an agreement to resolve the vast majority of its existing hernia mesh litigation for over $1 billion. | This is context. The point is Bard is used to settling products liability claims and 10-figure payouts are not foreign to Bard. |
| Likely defense position | Defendants will likely argue that infection, capsular contracture, implant shifting, and wound issues are known risks of breast surgery even without mesh. | The plaintiff needs a strong timeline, clear product identification, treatment records, and expert support linking the injury to the mesh. |
| Likely plaintiff position | Plaintiffs will focus on FDA language, lack of breast surgery clearance or approval, inadequate warnings, breast-focused marketing evidence, and serious revision injuries. | The cases most likely to pressure settlement are severe, well-documented, and not easily explained by unrelated risk factors. |
The lesson is simple. No one can honestly tell you the average payout yet. But a woman who lost an implant, needed mesh removal, had repeated infections, underwent multiple revisions, or lives with permanent deformity is not bringing a nuisance claim.
Settlement Value and Case Value
The best internal bra mesh cases show a clear injury after implantation, a specific mesh product, objective medical findings, additional treatment, and long-term harm. The weaker cases, if any, are built mostly on dissatisfaction with appearance or on vague discomfort without treatment.
Case value comes from damages and liability. You need both. Severe injury without product proof is hard. Strong warning evidence with a minor injury is also hard. The best cases have both: serious injury and a clear reason to blame the mesh product or warning failure.
| Value Driver | Why It Increases Pressure | Proof That Helps |
|---|---|---|
| Mesh removal or revision surgery | Additional surgery shows the complication was significant and medically confirmed. | Revision of operative reports, explant notes, pathology, photos, culture records, and surgeon findings. |
| Implant loss or failed reconstruction | Loss of reconstruction or implant changes the damages picture. This is not a minor cosmetic complaint. | Plastic surgery records, implant removal records, reconstruction plans, photographs, and future surgery recommendations. |
| Infection and wound breakdown | Infection can lead to hospitalization, tissue damage, scarring, implant loss, and repeated surgeries. | ER records, cultures, antibiotics, wound care notes, drainage records, labs, photos, and operative findings. |
| Permanent deformity or scarring | Visible permanent injury can raise pain, suffering, emotional distress, and body image damages. | Before and after photos, revision notes, scar treatment, mental health records, and surgeon opinions. |
| Manufacturer conduct | Evidence of weak warnings, breast-focused marketing, delayed label changes, or ignored complaints can increase settlement pressure. | Labels, FDA letters, sales documents, adverse event reports, internal company documents, and expert regulatory review. |
| Lost income and future care | Lost wages, unpaid revisions, travel, future surgery, and ongoing care increase economic damages. | Bills, insurance records, wage records, tax records, future surgery estimates, and disability records. |
The defense will focus on surgical risk, infection risk, prior mastectomy, radiation, smoking history, diabetes, wound healing problems, implant risks, and the surgeon’s independent choice. Those defenses can lower value if the records do not show a clear mesh-related failure.
Evidence That Can Support an Internal Bra Mesh Lawsuit
A viable case needs the medical records. The patient may know that something went wrong, but the lawsuit requires proof. Our attorneys need the operative report, product stickers, mesh name, lot number, implant records, follow-up notes, revision records, explant records, photographs, and all complaints to the surgeon or clinic.
Please do not throw away implant cards, product cards, discharge papers, revision paperwork, photos, or letters from the surgeon. If the mesh was removed, ask where it went. Sometimes explanted material is discarded. Sometimes it is sent to pathology. Sometimes it is returned to the manufacturer. That chain of custody can become important.
| Record | Why It Helps | Where To Look |
|---|---|---|
| Operative report | Shows the procedure, surgeon, mesh placement, implant pocket, and surgical technique. | Hospital chart, surgery center, surgeon’s office, plastic surgery records. |
| Product sticker sheet | Identifies the mesh brand, model, catalog number, lot number, and manufacturer. | Hospital supply record, implant log, operative packet, product card. |
| Follow-up notes | Shows complaints of pain, swelling, infection, asymmetry, hardening, drainage, or wound problems. | Surgeon’s office, portal messages, wound clinic, primary care records, ER records. |
| Revision or removal records | Confirms the complication was serious enough to require another procedure and may explain what the surgeon found. | Revision operative report, capsulectomy records, explant records, pathology, culture reports. |
| Photos and symptom timeline | The before-and-after story is often the heart of causation and damages. | Phone photos, text messages, portal messages, family notes, pain diary, pharmacy records. |
Deadlines to File an Internal Bra Mesh Lawsuit
Do not wait. There is no single national deadline because the rules vary by state and by claim type. Product liability, medical malpractice, failure to warn, warranty, fraud, and wrongful death claims may have different filing deadlines.
The deadline may depend on your surgery date, first symptom date, first mesh-related diagnosis, first revision recommendation, mesh removal date, or the date you reasonably should have connected the injury to the mesh. Some states also have statutes of repose that can cut off a claim after a set period tied to sale, manufacture, delivery, or implantation.
The biggest deadline trap is assuming the clock starts when the mesh is removed. The defense may argue it started earlier, when you first had pain, when the infection developed, when the implant shifted, when your doctor recommended revision, or when you were told the mesh may be causing problems. Contact a lawyer soon rather than later.
Get these dates reviewed by an attorney as soon as possible: original breast surgery, mesh implantation, first symptom, first complaint to a doctor, first infection treatment, first imaging, first revision recommendation, revision surgery, mesh removal, implant removal, and last follow-up.
What To Do Next
Call a lawyer early. If you had prior breast surgery, radiation, cancer treatment, smoking history, diabetes, thin tissue, wound healing problems, or prior implant complications, say that. Those facts do not automatically kill a case. Surprises later can.
Then turn to the product. Find the mesh name, surgeon, facility, implant date, revision date, and removal date, if applicable. If you do not yet have the records, start with the hospital or surgery center where the mesh was placed.
| Step | What To Do | Why It Helps |
|---|---|---|
| 1 | Gather operative reports, product stickers, implant logs, mesh cards, and model numbers. | Product identification controls the manufacturer’s claim and warning analysis. |
| 2 | Save revision records, removal records, pathology, cultures, wound care notes, and photographs. | Objective records strengthen the injury and causation argument. |
| 3 | Write down when pain, infection, swelling, hardening, shifting, or wound problems first started. | The case needs a clean timeline before the defense builds one against you. |
| 4 | Have the deadline reviewed before waiting for all records to arrive. | A strong claim can be lost if the filing deadline is missed. |
| 5 | If removal surgery is planned, ask whether the removed mesh or implant material can be preserved. | Preserved material can help in a defect case, especially if the device condition is disputed. |
Internal Bra Mesh Lawsuit FAQs
Calling an Internal Bra Mesh Lawyer
If your internal bra mesh caused infection, chronic pain, nerve damage, seroma, mesh exposure, implant shifting, capsular contracture, reconstruction failure, revision surgery, or removal surgery, contact our office today at 888-322-3010, or request a free online consultation.
